Average Co-Inventor Count = 1.32
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aragon Pharmaceuticals, Inc. (8 from 34 patents)
2. Genentech, Inc. (2 from 3,224 patents)
10 patents:
1. RE50642 - Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
2. RE49353 - Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
3. 10849888 - Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
4. 10799488 - Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
5. 10799489 - Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
6. 10052314 - Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
7. 10034860 - Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancer
8. 9884054 - Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
9. 9675586 - Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancer
10. 9340524 - Androgen receptor modulator and uses thereof